$3.180
+0.061 (+1.92%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
SAB Biotherapeutics Inc (SABS) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting SABS is Buy.
SAB Biotherapeutics Inc (SABS) 20-Day simple moving average is 2.92, while SAB Biotherapeutics Inc (SABS) share price is $—, making it Buy.
SAB Biotherapeutics Inc (SABS) 60-Day simple moving average is 3.31, while SAB Biotherapeutics Inc (SABS) share price is $—, making it Sell.
Technical Analysis for SABS
AI Technical SABSAs of 2026-11-03, the technical board for SAB Biotherapeutics Inc (SABS) reads buy: 5 indicators are flashing buy, 4 are indicating sell, and 4 are neutral. Price at $3.18 sits below the 5-day, 60-day and 200-day moving averages and above the 10-day and 20-day.
Momentum readings: RSI stands at 53.638, MACD stands at 0.0208 (Buy), Stochastic %K stands at 79.167, Stochastic %D stands at 85.452 and CCI stands at 93.425.
SABS trades below the 60-day SMA (3.31) and below the 200-day SMA (3.67). Immediate resistance sits at Classic R1 3.42, then R2 3.73. Support sits at Classic S1 2.78, then S2 2.46.
SAB Biotherapeutics Inc (SABS) Support & Resistance Level
SAB Biotherapeutics Inc (SABS) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 53.638 |
| STOCHk_14_3_3 | 79.167 |
| STOCHd_14_3_3 | 85.452 |
| CCI_20 | 93.425 |
| AO_5_34 | 0.201 |
| MOM_10 | 0.360 |
| MACD_12_26_9 | 0.021 |
SAB Biotherapeutics Inc (SABS) Relative Strength Index (RSI_14) is 53.638, creating a Neutral signal.
SAB Biotherapeutics Inc (SABS) Stochastic %K is 79.167, creating a Neutral signal.
SAB Biotherapeutics Inc (SABS) Stochastic %D is 85.452, creating a Sell signal.
SAB Biotherapeutics Inc (SABS) CCI_20 is 93.425, creating a Neutral signal.
SAB Biotherapeutics Inc (SABS) Awesome Oscillator (AO) is 0.201, creating a Buy signal.
SAB Biotherapeutics Inc (SABS) Momentum (MOM) is 0.360, creating a Buy signal.
SAB Biotherapeutics Inc (SABS) Moving Average Convergence Divergence (MACD) is 0.021, creating a Buy signal.
SAB Biotherapeutics Inc (SABS) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 3.236 | Sell |
| MA_10 | 3.112 | Buy |
| MA_20 | 2.920 | Buy |
| MA_60 | 3.313 | Sell |
| MA_200 | 3.669 | Sell |
| MA_250 | 3.685 | Sell |
SAB Biotherapeutics Inc (SABS) 5-Day simple moving average is 3.236, while SAB Biotherapeutics Inc (SABS) share price is $, making it a Sell.
SAB Biotherapeutics Inc (SABS) 10-Day simple moving average is 3.112, while SAB Biotherapeutics Inc (SABS) share price is $, making it a Buy.
SAB Biotherapeutics Inc (SABS) 20-Day simple moving average is 2.920, while SAB Biotherapeutics Inc (SABS) share price is $, making it a Buy.
SAB Biotherapeutics Inc (SABS) 60-Day simple moving average is 3.313, while SAB Biotherapeutics Inc (SABS) share price is $, making it a Sell.
SAB Biotherapeutics Inc (SABS) 200-Day simple moving average is 3.669, while SAB Biotherapeutics Inc (SABS) share price is $, making it a Sell.
SAB Biotherapeutics Inc (SABS) 250-Day simple moving average is 3.685, while SAB Biotherapeutics Inc (SABS) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.